Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity

SJ Cavalieri, GA Bohach, IS Snyder - Microbiological reviews, 1984 - Am Soc Microbiol
… The major band was probably AH since it was absent after electrophoresis of similar
preparations from a nonhemolytic mutant (SJ Cavalieri and I. S. Snyder, unpublished data). …

Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro

SJ Cavalieri, IS Snyder - Infection and Immunity, 1982 - Am Soc Microbiol
… (4; SJ Cavalieri and IS Snyder, J. Med. Microbiol., in press). … gradients as previously described
(Cavalieri and Snyder, in … and absorbed as described by Cavalieri and Snyder (in press)…

Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro

SJ Cavalieri, IS Snyder - Infection and immunity, 1982 - Am Soc Microbiol
To gain further evidence for the role of the Escherichia coli alpha-hemolysin in pathogenesis,
its in vitro effects on human peripheral leukocyte function were studied. Leukocytes …

Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis

SJ Cavalieri, JR Biehle… - Antimicrobial agents and …, 1995 - Am Soc Microbiol
The rise of multidrug-resistant Mycobacterium tuberculosis has complicated therapy for
tuberculosis and led us to search for a potentially active combination of drugs against these …

Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae …

…, K Propst, DJ Novak, SJ Cavalieri - Antimicrobial agents …, 2008 - Am Soc Microbiol
β-Lactamases produced by urine isolates from patients in long-term care facilities (LTCFs),
outpatient, clinics, and one hospital in a US community were characterized. A total of 1.3% of …

Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital

…, M Peyret, ES Moland, SJ Cavalieri… - Journal of clinical …, 2001 - Am Soc Microbiol
A study was designed to assess the impact of the VITEK 2 automated system and the Advanced
Expert System (AES) on the clinical laboratory of a typical university-based hospital. A …

Comparative evaluation of the E test for susceptibility testing of Nocardia species

JR Biehle, SJ Cavalieri, MA Saubolle… - … and infectious disease, 1994 - Elsevier
The E Test (PDM Epsilometer; AB Biodisk, Solna, Sweden) was compared with microbroth
dilution and disk diffusion for antimicrobial susceptibility testing of Nocardia as a collaborative …

Cytotoxic Activity of Partially Purified Escherichia Coli Alpha Haemolysin

SJ Cavalieri, IS Snyder - Journal of medical microbiology, 1982 - microbiologyresearch.org
Alpha haemolysin, produced by Escherichia coli, grown in a chemically defined medium, was
purified 19-fold and the endotoxin content reduced 2176-fold by ultrafiltration and glycerol-…

Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria

JR Biehle, SJ Cavalieri, MA Saubolle… - Journal of clinical …, 1995 - Am Soc Microbiol
MICs of amikacin, cefoxitin, ciprofloxacin, clarithromycin, doxycycline, and imipenem were
determined by Etest for 100 clinical strains of rapidly growing mycobacteria and compared …

Does antibiotic de-escalation for nosocomial pneumonia impact intensive care unit length of stay?

E Knaak, SJ Cavalieri, GN Elsasser… - Infectious Diseases in …, 2013 - journals.lww.com
Background Hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP),
and health care–associated pneumonia (HCAP) are associated with substantial morbidity, …